Dáil
Written answer
Medicinal Products
476. Deputy Gillian Toole asked the Minister for Health if information (details supplied) in relation to a series of matters regarding the policy, clinical and financial rationale for restricting access to long-acting injectable buprenorphine will be provided; and if she will make a statement on the matter. [33481/26]